Overview

Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin

Status:
Completed
Trial end date:
2020-09-09
Target enrollment:
Participant gender:
Summary
To evaluate the photosensitivity potential of BI 730357
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Ciprofloxacin